Asset
ABT-384
Abbott Laboratories Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01009216 | phase1 | completed | 2009-10-01 | 2010-11-01 | Abbott | A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid |
| NCT00968422 | phase1 | completed | 2009-08-01 | 2010-01-01 | Abbott | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects |
FDA applications (0)
This company has no applications containing this asset.